MTCH2 and cancer: Interrogation of TCGA Pan-Cancer dataset revealed that MTCH2 was highly expressed in several tumors despite different tissue origins, including cancers in the breast (BRCA), cervix (CESC), esophagus (ESCA), lung (LUSC) and brain (GBM) (Fig. 1a).